Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sean G. Parham's research has investigated topics within orthopedics and environmental toxicology. His publications include an analysis of pediatric patient transfers to a rural Level 1 Orthopedic Trauma Center, examining the necessity of these transfers. He has also evaluated the association of surgical setting with costs and complications in ankle arthrodesis using Medicare claims data and explored the management of chronic septic arthritis and osteomyelitis. In environmental science, Parham has studied the sensitivity of freshwater gastropod species to nickel exposure. His work also extends to metabolic research, with a publication on sclerostin antibody treatment in mice with Down Syndrome. Parham has a scholarly h-index of 2, with 2 total publications and 26 total citations. He has collaborated with researchers including Eric R. Siegel, Simon C. Mears, Brant Sachleben, and Shannon K. Brewer, all from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 2
- Publications: 2
- Citations: 27
Selected Publications
-
Evaluating the Association of Surgical Setting With Costs and Complications in Ankle Arthrodesis: Medicare Claims Analysis (2026)
-
Management of Chronic Septic Arthritis and Osteomyelitis Following Hallux Valgus Correction With Staged Antibiotic Cement Spacer and Subsequent Bulk Allograft Arthrodesis (2026)
-
Transfers of pediatric patients with isolated injuries to a rural Level 1 Orthopedic Trauma Center in the United States: are they all necessary? (2021)
-
Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice (2017)
Collaboration Network
Top Collaborators
- Management of Chronic Septic Arthritis and Osteomyelitis Following Hallux Valgus Correction With Staged Antibiotic Cement Spacer and Subsequent Bulk Allograft Arthrodesis
- Evaluating the Association of Surgical Setting With Costs and Complications in Ankle Arthrodesis: Medicare Claims Analysis
- Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
- Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
- Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
- Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
- Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
- Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
- Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
- Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
- Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
- Transfers of pediatric patients with isolated injuries to a rural Level 1 Orthopedic Trauma Center in the United States: are they all necessary?
- Transfers of pediatric patients with isolated injuries to a rural Level 1 Orthopedic Trauma Center in the United States: are they all necessary?
- Transfers of pediatric patients with isolated injuries to a rural Level 1 Orthopedic Trauma Center in the United States: are they all necessary?
- Transfers of pediatric patients with isolated injuries to a rural Level 1 Orthopedic Trauma Center in the United States: are they all necessary?
- Transfers of pediatric patients with isolated injuries to a rural Level 1 Orthopedic Trauma Center in the United States: are they all necessary?
Similar Researchers
Based on overlapping research topics